XVIVO: Positive top-line AMR result - Redeye

The initial topp-line result is positive and we look forward to the full results during Q2 2023. the top-line results confirms that AMR could be on track for a pivotal phase 3 study that could probably be initiated during 2024.

Länk till analysen i sin helhet: https://www.redeye.se/research/866851/xvivo-positive-top-line-amr-result?utm_source=finwire&utm_medium=RSS